EODData

NASDAQ, OCS: Oculis Holding Ag

05 Nov 25 15:59
LAST:

19.30

CHANGE:
 0.03
OPEN:
19.27
HIGH:
19.57
ASK:
0.00
VOLUME:
87.1K
CHG(%):
0.16
PREV:
19.27
LOW:
19.20
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Nov 2519.2719.5719.2019.3087.1K
04 Nov 2519.4019.4119.0519.2761.6K
03 Nov 2519.2820.0819.0019.48198.6K
31 Oct 2520.1620.5519.1319.28242.6K
30 Oct 2521.9821.9820.0020.09335.9K
29 Oct 2521.2121.6821.2021.5561.0K
28 Oct 2521.5021.5920.9121.0037.4K
27 Oct 2521.3321.7621.3021.5631.4K
24 Oct 2521.8421.8420.6121.25107.8K
23 Oct 2521.2821.5821.2221.3516.6K

COMPANY PROFILE

Name:Oculis Holding Ag
About:Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. Oculis Holding AG was formerly known as Oculis SA and changed its name to Oculis Holding AG in March 2023. The company was founded in 2017 and is based in Zug, Switzerland.
Sector:Healthcare
Industry:Biotechnology
Address:Bahnhofstrasse 20, Zug, Switzerland, 6300
Website:https://oculis.com
CIK:0001953530
ISIN:CH1242303498
FIGI:BBG01BJ1BHZ3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:63.63 
Forward P/E:-8.61 
PEG Ratio:-16.23 
Price to Sales:1,320.72 
Price to Book:7.05 
Operating Margin:-79.57 
Return on Assets:-0.30 
Return on Equity:-0.84 
EPS Ratio:-2.92 
Revenue:950.0K 
Shares:52.34M 
Market Cap:1.01B 

TECHNICAL INDICATORS

MA5:19.481.0%
MA10:20.415.8%
MA20:20.928.4%
MA50:18.822.5%
MA100:18.583.9%
MA200:18.902.1%
STO9:1.11 
STO14:1.10 
RSI14:28.61 
WPR14:-98.82 
MTM14:-2.45
ROC14:-0.11 
ATR:0.80 
Week High:21.9813.9%
Week Low:19.001.6%
Month High:22.0014.0%
Month Low:17.862.1%
Year High:23.0819.6%
Year Low:14.0037.9%